{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:18:49Z","timestamp":1777537129209,"version":"3.51.4"},"reference-count":92,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.euroneuro.2007.03.006","type":"journal-article","created":{"date-parts":[[2007,5,23]],"date-time":"2007-05-23T07:56:06Z","timestamp":1179906966000},"page":"687-695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Current issues in bipolar disorder: A critical review"],"prefix":"10.1016","volume":"17","author":[{"given":"Pierre","family":"Oswald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Souery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Lecrubier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabien","family":"Wyckaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Zohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Mendlewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.euroneuro.2007.03.006_bib1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1176\/ajp.142.2.192","article-title":"The nosologic status of borderline personality: clinical and polysomnographic study","volume":"142","author":"Akiskal","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib2","first-page":"149","article-title":"Frequence et aspects cliniques du trouble bipolaire II dans une etude multicentrique Fran\u00e7aise: EPIDEP","volume":"XXVII","author":"Allilaire","year":"2001","journal-title":"L'encephale"},{"issue":"11","key":"10.1016\/j.euroneuro.2007.03.006_bib3","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib5","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder, revision","volume":"159","author":"American Psychiatric Association","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00344125","article-title":"The course of affective disorders: II. Typology of bipolar manic\u2013depressive illness","volume":"226","author":"Angst","year":"1978","journal-title":"Arch. Psychiatr. Nervenkr."},{"key":"10.1016\/j.euroneuro.2007.03.006_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-0327(98)00142-6","article-title":"The emerging epidemiology of hypomania and bipolar II disorder","volume":"50","author":"Angst","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2007.03.006_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-0327(02)00322-1","article-title":"Toward a redefinition of bipolarity: epidemiology and proposed criteria for bipolar II, minor bipolar disorders and hypomania","volume":"73","author":"Angst","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2007.03.006_bib10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.157.5.816","article-title":"Age dependent decline of ADHD symptoms revisited: impact of remission definition and symptom subtype","volume":"157","author":"Biederman","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib13","series-title":"Bipolar Disorder","first-page":"191","article-title":"Pharmacological treatment of bipolar disorder","author":"Bowden","year":"2002"},{"issue":"12","key":"10.1016\/j.euroneuro.2007.03.006_bib11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group","volume":"271","author":"Bowden","year":"1994","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.euroneuro.2007.03.006_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2007.03.006_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"J. Clin. Psychiatry"},{"issue":"1 Suppl","key":"10.1016\/j.euroneuro.2007.03.006_bib16","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1097\/00004714-199202001-00004","article-title":"Bipolar affective disorder and substance abuse","volume":"12","author":"Brady","year":"1992","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.euroneuro.2007.03.006_bib17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group","volume":"60","author":"Calabrese","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2007.03.006_bib19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.euroneuro.2007.03.006_bib20","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0924-977X(03)00079-8","article-title":"Latest maintenance data on lamotrigine in bipolar disorder","volume":"13","author":"Calabrese","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2007.03.006_bib21","first-page":"571","article-title":"International Consensus Group on Bipolar I Depression Treatment Guidelines","volume":"65","author":"Calabrese","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2007.03.006_bib22","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib96","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4088\/JCP.v59n0204","article-title":"Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders","volume":"59","author":"Cassano","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2007.03.006_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00004850-198910000-00006","article-title":"A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder","volume":"4","author":"Cohn","year":"1989","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.euroneuro.2007.03.006_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2105\/AJPH.87.5.827","article-title":"Psychiatric disorders among American Indian and white youth in Appalachia: the Great Smoky Mountains Study","volume":"87","author":"Costello","year":"1997","journal-title":"Am. J. Public Health"},{"issue":"3","key":"10.1016\/j.euroneuro.2007.03.006_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2004.09.009","article-title":"Divalproex in the treatment of bipolar depression: a placebo-controlled study","volume":"85","author":"Davis","year":"2005","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.euroneuro.2007.03.006_bib26","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/00004583-199710000-00020","article-title":"Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype?","volume":"36","author":"Faraone","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"issue":"1","key":"10.1016\/j.euroneuro.2007.03.006_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(00)00213-5","article-title":"Attention deficit hyperactivity disorder with bipolar disorder in girls: further evidence for a familial subtype?","volume":"64","author":"Faraone","year":"2001","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.euroneuro.2007.03.006_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-0327(90)90127-T","article-title":"Epidemiology of mood disorders: a community survey in Florence","volume":"20","author":"Faravelli","year":"1990","journal-title":"J. Affect. Disord."},{"issue":"suppl 5","key":"10.1016\/j.euroneuro.2007.03.006_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1399-5618.2005.00250.x","article-title":"Newer treatment studies for bipolar depression","volume":"7","author":"Gao","year":"2005","journal-title":"J. Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2007.03.006_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.161.2.217","article-title":"Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials","volume":"161","author":"Geddes","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2007.03.006_bib97","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-0327(98)00175-X","article-title":"Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or untradian cycling","volume":"51","author":"Geller","year":"1998","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.euroneuro.2007.03.006_bib31","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1176\/appi.ajp.161.9.1537","article-title":"Antidepressants for bipolar depression: a systematic review of randomized, controlled trials","volume":"161","author":"Gijsman","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"4 Suppl","key":"10.1016\/j.euroneuro.2007.03.006_bib32","first-page":"3","article-title":"The British Association for Psychopharmacology guidelines for treatment of bipolar disorder: a summary","volume":"17","author":"Goodwin","year":"2003","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2007.03.006_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/15622970209150612","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders: Part I. Treatment of bipolar depression","volume":"3","author":"Grunze","year":"2002","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/15622970309167904","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Part II. Treatment of mania","volume":"4","author":"Grunze","year":"2003","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/15622970410029924","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Part III. Maintenance treatment","volume":"5","author":"Grunze","year":"2004","journal-title":"World J. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2007.03.006_bib36","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/archpsyc.1991.01810320036006","article-title":"Comorbidity of psychiatric diagnoses in anorexia nervosa","volume":"48","author":"Halmi","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1017\/S1461145704004651","article-title":"A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder","volume":"7","author":"Hirschfeld","year":"2004","journal-title":"Int. J. Neuropsychopharmacol"},{"issue":"7","key":"10.1016\/j.euroneuro.2007.03.006_bib37","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v64n0717","article-title":"The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder","volume":"64","author":"Hirschfeld","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2007.03.006_bib39","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","article-title":"Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial","volume":"161","author":"Hirschfeld","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib40","series-title":"Abstract of the 45th NCDEU Annual Meeting, Boca Raton, FL, June 6\u20139, 2005","article-title":"The impact of lamotrigine on core symptoms in the acute treatment of bipolar depresi\u00f3n","author":"Hirschfeld","year":"2005"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib42","first-page":"24","article-title":"Treatment options for bipolar mania","volume":"3","author":"Kasper","year":"2004","journal-title":"Clin. Approaches Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2007.03.006_bib47","series-title":"Medication Teatment of Bipolar Disorder 2004","article-title":"The Expert Consensus Guideline Series","author":"Keck","year":"2004"},{"issue":"4","key":"10.1016\/j.euroneuro.2007.03.006_bib45","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","article-title":"Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial","volume":"160","author":"Keck","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2007.03.006_bib46","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.euroneuro.2007.03.006_bib48","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.biopsych.2005.04.001","article-title":"Patterns and predictors of attention-deficit\/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication","volume":"57","author":"Kessler","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.187.3.229","article-title":"Risperidone in the treatment of acute mania: double-blind, placebo-controlled study","volume":"187","author":"Khanna","year":"2005","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2007.03.006_bib50","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1017\/S003329170400337X","article-title":"Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults","volume":"35","author":"Kooij","year":"2005","journal-title":"Psychol. Med."},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2007.03.006_bib51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-0327(02)00321-X","article-title":"Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients","volume":"73","author":"Koukopoulos","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2007.03.006_bib52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-0327(95)00008-B","article-title":"Comorbidity of obsessive\u2013compulsive disorder in bipolar disorder","volume":"34","author":"Kruger","year":"1995","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.euroneuro.2007.03.006_bib53","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00004583-199504000-00012","article-title":"Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course","volume":"34","author":"Lewinsohn","year":"1995","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.euroneuro.2007.03.006_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0447.108.s419.1.x","article-title":"Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark","volume":"419","author":"Licht","year":"2003","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.euroneuro.2007.03.006_bib55","first-page":"20","article-title":"Early Bipolar disorder and ADHD: differences and similarities in pre-pubertal and early adolescence","volume":"4","author":"Massat","year":"2005","journal-title":"Clin. Approaches Bipolar Disord."},{"issue":"3","key":"10.1016\/j.euroneuro.2007.03.006_bib56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0010-440X(95)90080-F","article-title":"Differences and similarities in mixed and pure mania","volume":"36","author":"McElroy","year":"1995","journal-title":"Compr. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2007.03.006_bib57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1176\/appi.ajp.158.3.420","article-title":"Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder","volume":"158","author":"McElroy","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2007.03.006_bib58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/0954026021000046155","article-title":"Mental health of children and adolescents in Great Britain","volume":"15","author":"Meltzer","year":"2003","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0165-0327(80)90013-0","article-title":"Antidepressant potentiation of 5-hydroxytryptophan by l-deprenyl in affective illness","volume":"2","author":"Mendlewicz","year":"1980","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.euroneuro.2007.03.006_bib60","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/archpsyc.60.9.904","article-title":"A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder","volume":"60","author":"Miklowitz","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.euroneuro.2007.03.006_bib61","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1176\/ajp.152.12.1793","article-title":"Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms","volume":"152","author":"Milberger","year":"1995","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2007.03.006_bib62","doi-asserted-by":"crossref","DOI":"10.1046\/j.1440-1665.2003.00520.x","article-title":"RANZCP clinical practice guidelines. Summary of guideline for the treatment of bipolar disorder","volume":"11","author":"Mitchell","year":"2003","journal-title":"Aust. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2007.03.006_bib63","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1399-5618.2005.00229.x","article-title":"The epidemiology of bipolar disorder: sociodemographic, disability and service utilization data from the Australian National Study of Low Prevalence (Psychotic) Disorders","volume":"7","author":"Morgan","year":"2005","journal-title":"Bipolar Disord."},{"issue":"6","key":"10.1016\/j.euroneuro.2007.03.006_bib64","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1176\/appi.ajp.158.6.906","article-title":"Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression","volume":"158","author":"Nemeroff","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.euroneuro.2007.03.006_bib65","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.biopsych.2005.01.036","article-title":"Clinical and diagnostic implications of lifetime attention-deficit\/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants","volume":"57","author":"Nierenberg","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2007.03.006_bib66","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archpsyc.58.9.844","article-title":"Excess mortality in bipolar and unipolar disorder in Sweden","volume":"58","author":"Osby","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"issue":"suppl 1","key":"10.1016\/j.euroneuro.2007.03.006_bib67","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0924-977X(06)80098-2","article-title":"Predictive factors of resistance to antidepressants in bipolar depression: results from a European multicentre study","volume":"16","author":"Oswald","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2007.03.006_bib68","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.euroneuro.2005.04.011","article-title":"Prevalence and burden of bipolar disorders in European countries","volume":"15","author":"Pini","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"19","key":"10.1016\/j.euroneuro.2007.03.006_bib69","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib98","series-title":"Postgrad. Med.; Spec No:1\u2013104","article-title":"The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000","author":"Sachs","year":"2000"},{"issue":"2","key":"10.1016\/j.euroneuro.2007.03.006_bib70","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.psc.2005.01.002","article-title":"Psychosocial treatments for bipolar disorders","volume":"28","author":"Scott","year":"2005","journal-title":"Psychiatr. Clin. North Am."},{"issue":"2\u20133","key":"10.1016\/j.euroneuro.2007.03.006_bib71","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0920-9964(03)00194-4","article-title":"Schizophrenia, schizoaffective and bipolar disorder within an epidemiologically complete, homogeneous population in rural Ireland: small area variation in rate","volume":"67","author":"Scully","year":"2004","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.euroneuro.2007.03.006_bib72","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.4088\/JCP.v65n1218","article-title":"Risperidone and paroxetine given singly and in combination for bipolar depression","volume":"65","author":"Shelton","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2007.03.006_bib73","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01.jcp.0000138772.40515.70","article-title":"Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD","volume":"24","author":"Simon","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.euroneuro.2007.03.006_bib74","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00005053-199211000-00006","article-title":"Bipolar II affective disorder in eating disorder inpatients","volume":"180","author":"Simpson","year":"1992","journal-title":"J. Nerv. Ment. Dis."},{"issue":"6","key":"10.1016\/j.euroneuro.2007.03.006_bib75","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005053-199406000-00007","article-title":"Substance abuse and bipolar affective disorder","volume":"182","author":"Sonne","year":"1994","journal-title":"J. Nerv. Ment. Dis."},{"issue":"4","key":"10.1016\/j.euroneuro.2007.03.006_bib76","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1176\/ajp.149.4.554","article-title":"Comorbidity in mania at first hospitalization","volume":"149","author":"Strakowski","year":"1992","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2007.03.006_bib77","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2190\/CM8E-46R5-9AJL-03FN","article-title":"The co-occurrence of mania with medical and other psychiatric disorders","volume":"24","author":"Strakowski","year":"1994","journal-title":"Int. J. Psychiatry Med."},{"issue":"7","key":"10.1016\/j.euroneuro.2007.03.006_bib78","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder","volume":"66","author":"Suppes","year":"2005","journal-title":"J. Clin. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.euroneuro.2007.03.006_bib79","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-0327(98)00056-1","article-title":"The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey","volume":"50","author":"Szadoczky","year":"1998","journal-title":"J. Affect. Disord."},{"issue":"2\u20133","key":"10.1016\/j.euroneuro.2007.03.006_bib80","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-0327(00)00310-4","article-title":"Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS)","volume":"68","author":"ten Have","year":"2002","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.euroneuro.2007.03.006_bib82","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/10673220500326425","article-title":"Bipolar depression: issues in diagnosis and treatment","volume":"13","author":"Thase","year":"2005","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib81","series-title":"Annual Meeting of the American Psychiatric Association, Toronto, Canada, research poster board NR600","article-title":"Confirmation of the efficacy of quetiapine monotherapy in bipolar depression in a second double-blind, placebo-controlled study: The BOLDER II Study","author":"Thase","year":"2006"},{"issue":"5","key":"10.1016\/j.euroneuro.2007.03.006_bib83","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group","volume":"156","author":"Tohen","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2007.03.006_bib84","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","article-title":"Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group","volume":"57","author":"Tohen","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2007.03.006_bib85","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","article-title":"Olanzapine versus divalproex in the treatment of acute mania","volume":"159","author":"Tohen","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2007.03.006_bib86","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","article-title":"Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study","volume":"160","author":"Tohen","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.euroneuro.2007.03.006_bib87","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine\u2013fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2007.03.006_bib88","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1192\/bjp.184.4.337","article-title":"Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone","volume":"184","author":"Tohen","year":"2004","journal-title":"Br. J. Psychiatry"},{"issue":"Suppl 4","key":"10.1016\/j.euroneuro.2007.03.006_bib91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1399-5618.2005.00212.x","article-title":"Atypical antipsychotics: newer options for mania and maintenance therapy","volume":"7","author":"Vieta","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2007.03.006_bib90","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/bjp.187.3.235","article-title":"Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial","volume":"187","author":"Vieta","year":"2005","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2007.03.006_bib99","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1017\/S0033291797005928","article-title":"Prevalence of mental disorders and psycosocial impairments in adolescents and young adults","volume":"28","author":"Wittchen","year":"1998","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.euroneuro.2007.03.006_bib92","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S146114570300333X","article-title":"Natural course and burden of bipolar disorders","volume":"6","author":"Wittchen","year":"2003","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"Suppl 3","key":"10.1016\/j.euroneuro.2007.03.006_bib94","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-5618.2005.00219.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies","volume":"7","author":"Yatham","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2007.03.006_bib95","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1399-5618.2006.00432.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007","volume":"8","author":"Yatham","year":"2006","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2007.03.006_bib100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-0327(93)90118-4","article-title":"Anxious and non-anxious bipolar disorder","volume":"29","author":"Young","year":"1993","journal-title":"J. Affect. Disord."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X07000831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X07000831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:49:14Z","timestamp":1760377754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X07000831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":92,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0924977X07000831"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2007.03.006","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current issues in bipolar disorder: A critical review","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2007.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}